BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
Hines
William C
WC
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America.
Bazarov
Alexey V
AV
Mukhopadhyay
Rituparna
R
Yaswen
Paul
P
D017398:Alternative Splicing; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D001943:Breast Neoplasms / Q000378:metabolism*; D000076246:CCCTC-Binding Factor; D002277:Carcinoma / Q000378:metabolism*; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000096:biosynthesis*; D000077209:Decitabine; D005091:Exons; D005347:Fibroblasts / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods; D012333:RNA, Messenger / Q000378:metabolism; D012097:Repressor Proteins / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014018:Tissue Distribution
D000076246:CCCTC-Binding Factor; C000619697:CTCF protein, human; C456540:CTCFL protein, human; D004268:DNA-Binding Proteins; D012333:RNA, Messenger; D012097:Repressor Proteins; D000077209:Decitabine; D001374:Azacitidine